| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/22/2006 | US20060134098 Immunoglobulin variable region cassette exchange |
| 06/22/2006 | US20060134092 Method of degrading hardly degradable protein |
| 06/22/2006 | US20060133291 Method and system for determining a signal quality metric in event of a CRC false positive |
| 06/22/2006 | CA2592344A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | CA2592343A1 Metabolites of cyclosporin analogs |
| 06/22/2006 | CA2589553A1 Use of flagellin in the immunotherapy of yersinia pestis |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/22/2006 | CA2587285A1 Actinomadura chromoprotein, apoprotein, and gene cluster |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1671647A1 Medicament for treating cancer |
| 06/21/2006 | EP1671097A2 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 06/21/2006 | EP1670931A2 Method for the production of fusion proteins in transgenic mammal milk |
| 06/21/2006 | EP1670918A1 Leader sequences for use in production of proteins |
| 06/21/2006 | EP1670897A2 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 06/21/2006 | EP1670822A2 Igf binding proteins |
| 06/21/2006 | EP1670817A2 Uses of spatial configuration to modulate protein function |
| 06/21/2006 | EP1670307A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
| 06/21/2006 | EP1587941A4 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
| 06/21/2006 | EP1583512A4 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 06/21/2006 | EP1410023B1 Methods using o6-alkylguanine-dna alkyltransferases |
| 06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
| 06/21/2006 | EP1255816B1 Tailored peptide synthetases, a method for their production and the use thereof |
| 06/21/2006 | EP1252315B1 Method for the production of a protein |
| 06/21/2006 | EP1220893B1 Medium for the protein-free and serum-free cultivation of cells |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1171583B1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
| 06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
| 06/21/2006 | EP0830456B1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
| 06/21/2006 | EP0811384B1 Muscle protein decomposition inhibitor containing il-6 receptor antibody |
| 06/21/2006 | EP0778888B1 Antigenically-marked non-infectious retrovirus-like particles |
| 06/21/2006 | EP0754231B1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
| 06/21/2006 | CN1789416A Human artificial chromosome containing human antibody lambda light chain |
| 06/21/2006 | CN1789411A Isolated nucleic acid molecules which encode T cell inducible factors (TIF), the proteins encoded, and uses thereof |
| 06/21/2006 | CN1260367C Fortified fusion protein possessing angiopoiesis-inhibiting and anti-tumour actions |
| 06/21/2006 | CN1260360C Lipid kinase |
| 06/21/2006 | CN1260358C cDNA segment of controlling growth of microspore of paddy, coded result and application |
| 06/21/2006 | CN1260357C Improved anti-IgE antibodies and method of improving polypeptides |
| 06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
| 06/20/2006 | USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins |
| 06/20/2006 | US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
| 06/20/2006 | US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 06/20/2006 | US7064194 Vectors for animal cells and utilization thereof |
| 06/20/2006 | US7064193 Therapeutic molecules |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7063976 Process for preparing beta-fructofuranosidase enzyme and a process for producing fructooligosaccharides |
| 06/20/2006 | US7063972 Cytochrome P450 monooxygenase CYP52A2A from Candida tropicalis |
| 06/20/2006 | US7063971 Phosphodiesterase enzymes |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases |
| 06/20/2006 | US7063962 DNA sequences for regulating transcription |
| 06/20/2006 | US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells. |
| 06/20/2006 | US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative |
| 06/20/2006 | US7063959 nucleic acids encoding SOC/CRAC calcium channel polypeptides that play an important role in the influx of extracellular calcium by mediating the refilling of intracellular calcium stores following their depletion |
| 06/20/2006 | US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity |
| 06/20/2006 | US7063953 Human voltage gated sodium channel β1A subunit and methods of use |
| 06/20/2006 | US7063950 Nucleic acids encoding human calcium channel and methods of use thereof |
| 06/20/2006 | US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 06/20/2006 | US7063845 Human anti-CD40 antibodies |
| 06/20/2006 | US7063841 Mammalian cell surface antigens; related reagents |
| 06/20/2006 | US7063840 Genes for receptor tyrosine kinases and their cognate ligands, their insertion into genetic engineered DNA vectors; useful in the diagnosis and treatment of neoplastic diseases |
| 06/20/2006 | CA2127700C Marek's disease virus recombinant poxvirus vaccine |
| 06/20/2006 | CA2049472C Monoclonal antibodies to leptosphaeria |
| 06/17/2006 | CA2585798A1 Process for the control of production of fine chemicals |
| 06/15/2006 | WO2006063292A1 Recombinant method for making multimeric proteins |
| 06/15/2006 | WO2006062684A2 Populations of reporter sequences and methods of their use |
| 06/15/2006 | WO2006062507A1 Methods of prescreening cells for nuclear transfer procedures |
| 06/15/2006 | WO2006062398A2 Methods for the production and secretion of modified peptides |
| 06/15/2006 | WO2006061851A2 Method for production of a therapeutically pure granulocyte macrophage - colony stimulating factor |
| 06/15/2006 | WO2006061174A2 Rhamnose promoter expression system |
| 06/15/2006 | WO2006060914A1 Plant proteins having an abscisic acid binding site and methods of use |
| 06/15/2006 | WO2006060903A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | WO2006031992A9 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes |
| 06/15/2006 | WO2006013572A3 Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
| 06/15/2006 | WO2005086698A3 Methods for altering t cell diversity |
| 06/15/2006 | US20060130170 Avian transgenesis using a chicken ovalbumin gene region |
| 06/15/2006 | US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP) |
| 06/15/2006 | US20060130160 Full-length human cDNAs encoding potentially secreted proteins |
| 06/15/2006 | US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains |
| 06/15/2006 | US20060128942 Method for protein isolation in anoxic conditions |
| 06/15/2006 | US20060127994 Aldehyde dehydrogenase gene |
| 06/15/2006 | US20060127989 Antigenic fragment of human T-lymphotropic virus |
| 06/15/2006 | US20060127986 Genetically engineered Recombinant actinomycete cells for use as tool for the generation of heterologous proteins; contains nucleic acid molecules which comprise at least two modules that encode a modular polyketide synthase |
| 06/15/2006 | US20060127985 Cytokine designated 4-1BB ligand and human receptor that binds thereto |
| 06/15/2006 | US20060127984 Modified Vaccinia virus Ankara for the vaccination of neonates |
| 06/15/2006 | US20060127983 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/15/2006 | US20060127982 Development of an asporogenic bacillus licheniformis and production of keratinase therefrom |
| 06/15/2006 | US20060127981 Targeting viruses using a modified sindbis glycoprotein |
| 06/15/2006 | US20060127980 Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| 06/15/2006 | US20060127979 Capable of generating high titer neutralizing antibody responses against at least two HPV types; prophylactic agents; diagnosis |
| 06/15/2006 | US20060127978 Nucleic acid recombination method, host cell and expression vector |
| 06/15/2006 | US20060127977 Family of mammalian G protein-coupled heteromeric receptors that specifically bind and/or are specifically activated by sweet taste stimuli such as natural and artificial sweeteners and are expressed by recombinant host cells |
| 06/15/2006 | US20060127976 Use of oxalate deficient aspergillus niger strains for producing a polypeptide |
| 06/15/2006 | US20060127975 Method for culturing cells in order to produce substances |
| 06/15/2006 | US20060127974 Mpg added to fermentation |
| 06/15/2006 | US20060127973 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof |
| 06/15/2006 | US20060127970 Controlling proteolytic action in natural rubber latex |